Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
8 hedge funds and large institutions have $1.61M invested in Yield10 Bioscience, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
46% less capital invested
Capital invested by funds: $2.95M → $1.61M (-$1.34M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
FCG Advisors
Chatham,
New Jersey
|
+$20.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.2K |
| 2 |
MCM
McRae Capital Management
Morristown,
New Jersey
|
-$11K |
YTEN Hedge Fund Activity: Q3 2016 in Review
8 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2016, worth a combined $1.61M — down 46% from $2.95M a quarter earlier.
Fund positioning in YTEN was balanced in Q3 2016: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was FCG Advisors, adding an estimated $20.3K. The largest seller was Vanguard Group, cutting an estimated $15.2K.
- 8 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $1.61M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2016, down 46% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2016 and 1 closed out, a net change of 0 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2016 was FCG Advisors, an estimated $20.3K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2016 was Vanguard Group, an estimated $15.2K sold.
Based on aggregated 13F filings for Q3 2016.